2.67
price down icon2.20%   -0.06
after-market Dopo l'orario di chiusura: 2.70 0.03 +1.12%
loading
Precedente Chiudi:
$2.73
Aprire:
$2.695
Volume 24 ore:
4.05M
Relative Volume:
1.04
Capitalizzazione di mercato:
$414.17M
Reddito:
-
Utile/perdita netta:
$-110.78M
Rapporto P/E:
-2.4953
EPS:
-1.07
Flusso di cassa netto:
$-75.59M
1 W Prestazione:
+10.33%
1M Prestazione:
+19.73%
6M Prestazione:
-42.08%
1 anno Prestazione:
-66.87%
Intervallo 1D:
Value
$2.52
$2.72
Intervallo di 1 settimana:
Value
$2.28
$2.82
Portata 52W:
Value
$1.15
$9.79

Humacyte Inc Stock (HUMA) Company Profile

Name
Nome
Humacyte Inc
Name
Telefono
919-313-9633
Name
Indirizzo
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Name
Dipendente
220
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-28
Name
Ultimi documenti SEC
Name
HUMA's Discussions on Twitter

Confronta HUMA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
HUMA
Humacyte Inc
2.67 356.77M 0 -110.78M -75.59M -1.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Humacyte Inc Stock (HUMA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-14 Ripresa H.C. Wainwright Buy
2024-12-20 Reiterato H.C. Wainwright Buy
2023-12-11 Iniziato H.C. Wainwright Buy
2023-08-14 Aggiornamento Piper Sandler Underweight → Neutral
2023-06-22 Iniziato Cantor Fitzgerald Overweight
2022-05-16 Downgrade Piper Sandler Overweight → Underweight
2021-10-29 Iniziato Cowen Outperform
2021-09-24 Iniziato Oppenheimer Outperform
2021-09-22 Iniziato BTIG Research Buy
2021-09-16 Iniziato Piper Sandler Overweight
Mostra tutto

Humacyte Inc Borsa (HUMA) Ultime notizie

pulisher
Jul 24, 2025

Will Humacyte Inc. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Humacyte rises on Symvess sale to military treatment facility - MSN

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Humacyte Inc. Equity Warrant stock priceExplosive trading opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Humacyte, Inc. shares rise 1.47% after-hours after announcing first Symvess sale to U.S. Military Treatment Facility. - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Humacyte Inc. Equity Warrant Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Humacyte stock rises after first Symvess sale to US Military facility - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Humacyte Announces First Symvess™ Sale to Military Treatment Facility - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Humacyte Inc. stock priceFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Humacyte Inc. stockMassive profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Humacyte Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Humacyte Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Humacyte Inc. Equity Warrant stockConsistently profitable trades - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know - MSN

Jul 19, 2025
pulisher
Jul 17, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 16, 2025

Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026 - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

HUMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Humacyte, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Jul 15, 2025

Humacyte Inc Azioni (HUMA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):